PortfoliosLab logoPortfoliosLab logo
LLY vs. BTAL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

LLY vs. BTAL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eli Lilly and Company (LLY) and AGF U.S. Market Neutral Anti-Beta Fund (BTAL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LLY achieves a 7.08% return, which is significantly higher than BTAL's -15.84% return. Over the past 10 years, LLY has outperformed BTAL with an annualized return of 32.37%, while BTAL has yielded a comparatively lower -4.60% annualized return.


LLY

1D
-2.73%
1M
4.40%
6M
10.82%
YTD
7.08%
1Y
49.67%
3Y*
36.36%
5Y*
38.34%
10Y*
32.37%
ALL TIME*
16.05%

BTAL

1D
0.00%
1M
10.49%
6M
-12.25%
YTD
-15.84%
1Y
-25.57%
3Y*
-9.44%
5Y*
-4.30%
10Y*
-4.60%
ALL TIME*
-3.86%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LLY vs. BTAL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LLY
Eli Lilly and Company
7.08%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%
BTAL
AGF U.S. Market Neutral Anti-Beta Fund
-15.84%-20.17%12.83%-15.11%20.48%-6.81%-13.86%1.07%15.13%-2.13%

Correlation

The correlation between LLY and BTAL is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.07

Correlation (3Y)
Calculated over the trailing 3-year period

-0.10

Correlation (5Y)
Calculated over the trailing 5-year period

-0.06

Correlation (10Y)
Calculated over the trailing 10-year period

-0.07

Correlation (All Time)
Calculated using the full available price history since Sep 13, 2011

-0.11

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LLY vs. BTAL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LLY
LLY Risk / Return Rank: 8080
Overall Rank
LLY Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 7878
Sortino Ratio Rank
LLY Omega Ratio Rank: 7979
Omega Ratio Rank
LLY Calmar Ratio Rank: 8181
Calmar Ratio Rank
LLY Martin Ratio Rank: 8181
Martin Ratio Rank

BTAL
BTAL Risk / Return Rank: 22
Overall Rank
BTAL Sharpe Ratio Rank: 11
Sharpe Ratio Rank
BTAL Sortino Ratio Rank: 22
Sortino Ratio Rank
BTAL Omega Ratio Rank: 22
Omega Ratio Rank
BTAL Calmar Ratio Rank: 33
Calmar Ratio Rank
BTAL Martin Ratio Rank: 11
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LLY vs. BTAL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and AGF U.S. Market Neutral Anti-Beta Fund (BTAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LLYBTALDifference
Sharpe ratioReturn per unit of total volatility

+2.39

Sortino ratioReturn per unit of downside risk

+3.48

Omega ratioGain probability vs. loss probability

1.25

0.83

+0.42

Calmar ratioReturn relative to maximum drawdown

2.15

-0.74

+2.90

Martin ratioReturn relative to average drawdown

5.36

-1.39

+6.75

LLY vs. BTAL - Sharpe Ratio Comparison

The current LLY Sharpe Ratio is 1.30, which is higher than the BTAL Sharpe Ratio of -1.09. The chart below compares the historical Sharpe Ratios of LLY and BTAL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LLY vs. BTAL - Drawdown Comparison

The maximum LLY drawdown since its inception was -68.24%, which is greater than BTAL's maximum drawdown of -52.70%. Use the drawdown chart below to compare losses from any high point for LLY and BTAL.


Loading charts...

Drawdown Indicators


LLYBTALDifference

Max Drawdown

Largest peak-to-trough decline

-68.24%

-52.70%

-15.54%

Max Drawdown (1Y)

Largest decline over 1 year

-23.18%

-34.57%

+11.39%

Max Drawdown (3Y)

Largest decline over 3 years

-34.48%

-47.83%

+13.35%

Max Drawdown (5Y)

Largest decline over 5 years

-34.48%

-47.83%

+13.35%

Max Drawdown (10Y)

Largest decline over 10 years

-34.48%

-52.70%

+18.22%

Current Drawdown

Current decline from peak

-7.18%

-47.55%

+40.37%

Average Drawdown

Average peak-to-trough decline

-19.18%

-22.19%

+3.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.29%

18.40%

-9.11%

Volatility

LLY vs. BTAL - Volatility Comparison

Eli Lilly and Company (LLY) has a higher volatility of 10.15% compared to AGF U.S. Market Neutral Anti-Beta Fund (BTAL) at 7.95%. This indicates that LLY's price experiences larger fluctuations and is considered to be riskier than BTAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LLYBTALDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.15%

7.95%

+2.20%

Volatility (6M)

Calculated over the trailing 6-month period

27.46%

17.50%

+9.96%

Volatility (1Y)

Calculated over the trailing 1-year period

38.57%

23.51%

+15.06%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.56%

19.27%

+13.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

30.33%

17.40%

+12.93%

Dividends

LLY vs. BTAL - Dividend Comparison

LLY's dividend yield for the trailing twelve months is around 0.56%, less than BTAL's 2.96% yield.


PositionTTM20252024202320222021202020192018201720162015
BTAL
AGF U.S. Market Neutral Anti-Beta Fund
2.96%2.49%3.49%6.14%1.01%0.00%0.00%0.88%0.39%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.56%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%

Frequently Asked Questions


LLY and BTAL have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LLY has higher volatility (10.15%) compared to BTAL (7.95%). In terms of maximum drawdown, LLY dropped -68.24% vs BTAL's -52.70%.

LLY currently has the higher Sharpe Ratio (1.30 vs -1.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LLY and BTAL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer